ArticleThe mental health clinician2025
A primary care psychiatric pharmacist clinic for addressing hypertension and mental health disparities in black patients.
Article in The mental health clinician, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A psychiatric pharmacist can play a critical role in addressing health disparities in black patients by managing both psychiatric and nonpsychiatric conditions. Black patients experience disparities in the treatment of both hypertension and mental health disorders, highlighting the need for innovative care models. This paper describes the integration of a psychiatric pharmacist into a primary care clinic to provide comprehensive medication management for hypertension, psychiatric disorders, and tobacco use disorder in black patients. The integration of this model faced challenges, including limited pharmacist funding and provider unfamiliarity with the psychiatric pharmacist's role. We describe how these barriers can be mitigated through relationship-building and demonstrating the pharmacist's value in patient care. This model highlights the potential for psychiatric pharmacists to provide whole-person care, addressing both psychiatric and nonpsychiatric conditions and working to reduce health disparities. The implementation of psychiatric pharmacists in primary care settings may serve as a strategy to improve equitable health care access and outcomes for black patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.